Edwards Lifesciences (EW) Profit After Tax Growth (3y) (2012 - 2026)
Edwards Lifesciences (EW) Profit After Tax Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 128.56 Bn | 125.08 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 119.26 Bn | 110.04 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 49.66% |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | -7.65% |
| 6 | Dexcom | 34.55 Bn | 32.61 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 9.79% |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | 97.37% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 15.46% |
| 10 | Zimmer Biomet Holdings | 19.31 Bn | 18.90 Bn | 1.54 Bn | -1.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.65% |
| Mar 31, 2026 | 3.79% |
| Dec 31, 2025 | -33.08% |
| Sep 30, 2025 | -5.37% |
| Jun 30, 2025 | -6.56% |
| Mar 31, 2025 | -0.90% |
| Dec 31, 2024 | 0.96% |
| Sep 30, 2024 | 108.20% |
| Jun 30, 2024 | 205.51% |
| Mar 31, 2024 | 220.95% |
| Dec 31, 2023 | 2.48% |
| Sep 30, 2023 | 5.67% |
| Jun 30, 2023 | 272.72% |
| Mar 31, 2023 | 339.90% |
| Dec 31, 2022 | -10.56% |
| Sep 30, 2022 | 7.73% |
| Jun 30, 2022 | 413.58% |
| Mar 31, 2022 | 419.71% |
| Dec 31, 2021 | 263.17% |
| Sep 30, 2021 | 14.61% |